Pancreatic Cancer Research

ResearcherMinia UniversityActive in the last 2 years

Saleh K Saleh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2234-7561; OpenAlex author ID A5026178149. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
12 (principal investigator on 12)
Grants
0
Labs led
0
Collaborators
1
Papers, trials and grants by year

2024: 1 trial · 2025: 10 trials · 2026: 1 paper, 1 trial

Papers 1

  1. Mesopancreas excision in pancreatic ductal adenocarcinoma: recurrence patterns - a single-arm descriptive study. Co-author DOI 10.1186/s12957-026-04459-4↗

Trials 12

  1. Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy Principal investigator NCT07328607↗
  2. External Pancreatic Stent in Pancreaticojejunostomy Principal investigator NCT06743516↗
  3. Reinforced Pancreaticojejunostomy With or Without glubran2 Principal investigator NCT06756074↗
  4. Laparoscopic Pancreaticoduodenectomy Principal investigator NCT07009119↗
  5. Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy Principal investigator NCT07022015↗
  6. Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer Principal investigator NCT07081360↗
  7. Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate) Principal investigator NCT07132541↗
  8. Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD Principal investigator NCT07139236↗
  9. Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas Principal investigator NCT07155525↗
  10. Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate Principal investigator NCT07230509↗
  11. Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer Principal investigator NCT07232810↗
  12. Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma. Principal investigator NCT07148830↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rabeh Khairy Saleh · 1 shared paper, 2026 · strength 0.32

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.